ISTH 2020 Congress

July 12-14, 2020. Virtual Congress.

• Arterial Thromboembolism (109)
  • Acute Coronary Syndromes (23)
  • Atherosclerosis (26)
  • Cardiovascular Risk Factors (33)
  • Cerebrovascular Disorders (21)
  • Peripheral Artery Disease (6)
• Coagulation and Natural Anticoagulants (279)
  • Animal Models in Thrombosis and Hemostasis (30)
  • Coagulation Factors and Inhibitors (84)
  • Contact Pathway (24)
  • Critical Care and Perioperative (50)
  • FVIII/IX (30)
  • Hemostasis and Organ Dysfunction (12)
  • Microparticles (13)
  • Protein C Pathway (9)
  • Regulation of Coagulation (21)
  • Tissue Factor Pathway (6)
• Diagnostics and OMICs (277)
  • Biomarkers of Thrombosis and Hemostasis (52)
  • Blood Components and Management (11)
  • Cellular Therapies (2)
  • Epigenetics, OMICs and Bioinformatics (10)
  • Laboratory Diagnostics (196)
  • Nanotechnology and Novel Biomolecules (6)
• Fibrinolysis and Proteolysis (57)
  • Fibrinogen and Factor XIII (27)
  • Fibrinolytic Factors and Inhibitors (21)
  • Thrombolytic Therapy (9)
• Hemophilia and Rare Bleeding Disorders (414)
  • Acquired Hemorrhagic Coagulation Disorders (24)
  • Disseminated Intravascular Coagulation (5)
  • Hemophilia - Basic (54)
  • Hemophilia - Clinical (208)
  • Hemophilia Gene Therapy (27)
  • Management of Bleeding and Trauma (24)
  • Novel Biotherapeutics in Hemophilia (26)
  • Rare Bleeding Disorders (46)
• Nurses (16)
  • Nurses and Allied Health (16)
• Pediatrics (78)
  • Bleeding in Neonates and Children (30)
  • Thrombosis in Neonates and Children (48)
• Platelet Disorders and von Willebrand Disease (249)
  • Acquired Thrombocytopenias (61)
  • Antiplatelet Therapy (19)
  • HIT (21)
  • Inherited Thrombocytopenias (21)
  • Platelet Antagonists and Novel Therapeutics (10)
  • Platelet Function Disorders, Acquired (13)
  • Platelet Function Disorders, Hereditary (32)
  • von Willebrand Factor Biology (16)
  • VWF and von Willebrand Factor Disorders - Clinical Conditions (56)
• Platelets and Megakaryocytes (148)
  • Megakaryocytes and Thrombopoiesis (21)
  • Platelet Function and Interactions (84)
  • Platelet Proteomics and Genomics (9)
  • Platelet Receptors (15)
  • Platelet Signaling (19)
• Role of Hemostatic System in Cancer, Inflammation and Immunity (76)
  • Coagulation Proteins Beyond Hemostasis (11)
  • Complement and Hemostatic System (4)
  • Infection and Hemostatic Factors (8)
  • Platelets and Cancer (14)
  • Platelets and Infection (7)
  • Platelets and Inflammation (28)
  • Proteases and Cancer (4)
• Thrombotic Microangiopathies (90)
  • ADAMTS13 and TTP (40)
  • Antiphospholipid Syndrome (44)
  • HUS (2)
  • Non HUS/TTP Microangiopathies (4)
• Vascular Biology (83)
  • Blood Cells and Vessel Wall (21)
  • Endothelial Cell Signaling (11)
  • Inflammation and Sepsis (26)
  • Innate and Adaptive Immunity (12)
  • Non-coding RNAs (5)
  • Protease Activated Receptors (4)
  • Stem Cells and Vascular Cell Growth (4)
• Venous Thromboembolism and Cardioembolism (436)
  • Artificial Valves (1)
  • Atrial Fibrillation (51)
  • Cancer Associated Thrombosis (80)
  • Genetic Risk Factors of Thrombosis (18)
  • Post-thrombotic Syndrome (19)
  • Thrombophilia (30)
  • Visceral Vein Thrombosis (8)
  • VTE Diagnosis (45)
  • VTE Epidemiology (45)
  • VTE Prophylaxis (37)
  • VTE Treatment (102)
• Women Health (81)
  • Estrogens and Progestinics (10)
  • Pregnancy and Pregnancy Complications (71)